Pembrolizumab in combination with platinum-based chemotherapy appeared to be a safe and effective first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma, according to results of the randomized phase 3 KEYNOTE-048 study published in The Lancet. Researchers also deemed first-line monotherapy with pembrolizumab (Keytruda, Merck) to be appropriate for patients with
Hepatic steatosis was prevalent among 52% of adults with or without type 2 diabetes and no known history of metabolic dysfunction-associated steatotic liver disease, according…
The FDA approved Exact Sciences’ Cologuard Plus multitarget stool DNA test to screen adults aged 45 years or older at average risk for colorectal cancer,…
Despite a twofold increase in colorectal cancer screening among average-risk individuals aged 45 to 49 years after the 2021 recommendation, disparities in socioeconomic status and…
Treatment of obesity-related HF with preserved ejection fraction with semaglutide 2.4 mg improved body weight, physical function and HF symptoms regardless of the extent of…
Selling a medical practice is a complex transaction that involves not only the assets of the practice itself but also implicates associated real estate.
A recent investigation into the molecular roots of systemic lupus erythematosus may point the way toward a new generation of therapeutic targets, according to the…
Nearly two-thirds of patients with excessive alcohol use and a high fibrosis-4 index were not referred for liver-related care, with fewer referrals among those with…
Among Chinese adults with bronchiectasis and exacerbations in the past year, 24-week dipeptidylpeptidase-1 inhibitor HSK31858 lowered exacerbation incidence, according to a poster at the European…
Using continuous temperature monitoring data from patients with COPD, an AI was able to predict exacerbations, according to a poster presented at the European Respiratory…
The Asthma and Allergy Foundation of America, also known as AAFA, released its yearly list of the most difficult cities for people with asthma to…
